Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Mackey, JR; Ramos-Vazquez, M; Lipatov, O; McCarthy, N; Krasnozhon, D; Semiglazov, V; Manikhas, A; Gelmon, KA; Konecny, GE; Webster, M; Hegg, R; Verma, S; Gorbunova, V; Gerges, DA; Thireau, F; Fung, H; Simms, L; Buyse, M; Ibrahim, A; Martin, M.

Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer

JOURNAL OF CLINICAL ONCOLOGY. 2015; 33(2): 141-38 Nº de citas: 101 [doi:10.1200/JCO.2014.57.1513]

Pineda, S; Gomez-Rubio, P; Picornell, A; Bessonov, K; Marquez, M; Kogevinas, M; Real, FX; Van Steen, K; Malats, N.

Framework for the Integration of Genomics, Epigenomics and Transcriptomics in Complex Diseases

HUMAN HEREDITY. 2015; 79(3-4): 124-136 Nº de citas: 17 [doi:10.1159/000381184]

Martin, M; Herrero, A; Echavarria, I.

BREAST CANCER

ARBOR-CIENCIA PENSAMIENTO Y CULTURA. 2015; 191(773): Nº de citas: 8 [doi:10.3989/arbor.2015.773n3004]

Martinez-Laperche, C; Noriega, V; Kwon, M; Balsalobre, P; Gonzalez-Rivera, M; Serrano, D; Anguita, J; Gayoso, J; Diez-Martin, JL; Buno, I.

Achievement of early complete donor chimerism in CD25(+)-activated leukocytes is a strong predictor of the development of graft-versus-host-disease after stem cell transplantation

EXPERIMENTAL HEMATOLOGY. 2015; 43(1): 4-13 Nº de citas: 4 [doi:10.1016/j.exphem.2014.09.003]

Rosmarin, D; Palles, C; Pagnamenta, A; Kaur, K; Pita, G; Martin, M; Domingo, E; Jones, A; Howarth, K; Freeman-Mills, L; Johnstone, E; Wang, HT; Love, S; Scudder, C; Julier, P; Fernandez-Rozadilla, C; Ruiz-Ponte, C; Carracedo, A; Castellvi-Bel, S; Castells, A; Gonzalez-Neira, A; Taylor, J; Kerr, R; Kerr, D; Tomlinson, I.

A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS

GUT. 2015; 64(1): 111-120 Nº de citas: 94 [doi:10.1136/gutjnl-2013-306571]

Martin, AJM; Puig, CF; Martin, LMN; Garcia, PB; Jimenez, MM.

Clinical guide SEOM on venous thromboembolism in cancer patients

Clinical & Translational Oncology. 2014; 16(12): 1079-1090 Nº de citas: 21 [doi:10.1007/s12094-014-1238-y]

De las Penas, R; Escobar, Y; Henao, F; Blasco, A; Rodriguez, CA.

SEOM guidelines on hydroelectrolytic disorders

Clinical & Translational Oncology. 2014; 16(12): 1051-1059 Nº de citas: 14 [doi:10.1007/s12094-014-1234-2]

Saura, C; Garcia-Saenz, JA; Xu, BH; Harb, W; Moroose, R; Pluard, T; Cortes, J; Kiger, C; Germa, C; Wang, KM; Martin, M; Baselga, J; Kim, SB.

Safety and Efficacy of Neratinib in Combination With Capecitabine in Patients With Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

JOURNAL OF CLINICAL ONCOLOGY. 2014; 32(32): 3626 Nº de citas: 114 [doi:10.1200/JCO.2014.56.3809]

Prat, A; Lluch, A; Albanell, J; Barry, WT; Fan, C; Chacon, JI; Parker, JS; Calvo, L; Plazaola, A; Arcusa, A; Segui-Palmer, MA; Burgues, O; Ribelles, N; Rodriguez-Lescure, A; Guerrero, A; Ruiz-Borrego, M; Munarriz, B; Lopez, JA; Adamo, B; Cheang, MCU; Li, Y; Hu, Z; Gulley, ML; Vidal, MJ; Pitcher, BN; Liu, MC; Citron, ML; Ellis, MJ; Mardis, E; Vickery, T; Hudis, CA; Winer, EP; Carey, LA; Caballero, R; Carrasco, E; Martin, M; Perou, CM; Alba, E.

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

BRITISH JOURNAL OF CANCER. 2014; 111(8): 1532-1541 Nº de citas: 109 [doi:10.1038/bjc.2014.444]

Martorell, PM; de las Heras, BB; Perez-Fidalgo, JA; Alvaro, MH; Martin, M; Albanell, J; Hernandez, AL.

Subcutaneous trastuzumab: drug development and current position

Clinical & Translational Oncology. 2014; 16(10): 859-864 Nº de citas: 2 [doi:10.1007/s12094-014-1181-y]

Martin, AJM; Alfonso, PG; Blanco, ABR; Ramirez, SP; Codesido, MB; Jimenez, MM.

Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana's predictive model

Clinical & Translational Oncology. 2014; 16(10): 927-930 Nº de citas: 50 [doi:10.1007/s12094-014-1165-y]

Castello, A; Pollan, M; Buijsse, B; Ruiz, A; Casas, AM; Baena-Canada, JM; Lope, V; Antolin, S; Ramos, M; Munoz, M; Lluch, A; de Juan-Ferre, A; Jara, C; Jimeno, MA; Rosado, P; Diaz, E; Guillem, V; Carrasco, E; Perez-Gomez, B; Vioque, J; Boeing, H; Martin, M.

Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study

BRITISH JOURNAL OF CANCER. 2014; 111(7): 1454-1462 Nº de citas: 158 [doi:10.1038/bjc.2014.434]

Calvo, FA; Sole, CV; Rivera, S; Meirino, R; Lizarraga, S; Infante, MA; Boldo, E; Ferrer, C; Marsiglia, H; Deutsch, E.

The use of radiotherapy for early breast cancer in woman at different ages

Clinical & Translational Oncology. 2014; 16(8): 680-685 Nº de citas: 9 [doi:10.1007/s12094-014-1164-z]

de Andres, C; Tejera-Alhambra, M; Alonso, B; Valor, L; Teijeiro, R; Ramos-Medina, R; Mateos, D; Faure, F; Sanchez-Ramon, S.

New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids

JOURNAL OF NEUROIMMUNOLOGY. 2014; 270(1-2): 37-44 Nº de citas: 54 [doi:10.1016/j.jneuroim.2014.02.003]

Ramos-Medina, R; Garcia-Segovia, A; Gil, J; Carbone, J; de la Cruz, AA; Seyfferth, A; Alonso, B; Alonso, J; Leon, JA; Alecsandru, D; Melia, E; de Albornoz, EC; Ordonez, D; Santillan, I; Verdu, V; de Morales, JMGR; Lopez-Hoyos, M; Larios, AL; Sampalo, A; Caballero, P; Quintana, LO; Fernandez-Cruz, E; Sanchez-Ramon, S.

Experience in IVIg Therapy for Selected Women with Recurrent Reproductive Failure and NK Cell Expansion

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2014; 71(5): 458-466 Nº de citas: 59 [doi:10.1111/aji.12217]

Wheeler, HE; Gonzalez-Neira, A; Pita, G; de la Torre-Montero, JC; Alonso, R; Lopez-Fernandez, LA; Alba, E; Martin, M; Dolan, ME.

Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses

Pharmacogenetics and Genomics. 2014; 24(5): 231-237 Nº de citas: 14 [doi:10.1097/FPC.0000000000000037]

Rosmarin, D; Palles, C; Church, D; Domingo, E; Jones, A; Johnstone, E; Wang, HT; Love, S; Julier, P; Scudder, C; Nicholson, G; Gonzalez-Neira, A; Martin, M; Sargent, D; Green, E; McLeod, H; Zanger, UM; Schwab, M; Braun, M; Seymour, M; Thompson, L; Lacas, B; Boige, V; Ribelles, N; Afzal, S; Enghusen, H; Jensen, SA; Etienne-Grimaldi, MC; Milano, G; Wadelius, M; Glimelius, B; Garmo, H; Gusella, M; Lecomte, T; Laurent-Puig, P; Martinez-Balibrea, E; Sharma, R; Garcia-Foncillas, J; Kleibl, Z; Morel, A; Pignon, JP; Midgley, R; Kerr, D; Tomlinson, I.

Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

JOURNAL OF CLINICAL ONCOLOGY. 2014; 32(10): 1031-1039 Nº de citas: 208 [doi:10.1200/JCO.2013.51.1857]

Romero, A; Prat, A; Garcia-Saenz, JA; del Prado, N; Pelayo, A; Furio, V; Roman, JM; de la Hoya, M; Diaz-Rubio, E; Perou, CM; Clades, T; Martin, M.

Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient's management and therapy selection

Clinical & Translational Oncology. 2014; 16(4): 386-394 Nº de citas: 21 [doi:10.1007/s12094-013-1088-z]